Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

February 2004 · Vol. 16, No. 2

Electronic fetal monitoring: The difficulty of linking patterns with outcomes

Nonreassuring tracings don’t always correlate with adverse outcomes, and vice versa. A look at what we know and don’t know from evidence to date.


Dr. Sorem is assistant clinical professor of obstetrics and gynecology, Stanford University School of Medicine, Stanford, Calif. Dr. Druzin is chief, division of maternal-fetal medicine, Stanford University Medical Center, and professor of obstetrics and gynecology, Stanford University School of Medicine, Stanford, Calif.

KIMBERLEE  SOREM,  MD; MAURICE  LESLIE DRUZIN,  MD

KEY POINTS

  • High-risk pattern. Fetuses at greatest risk include those with marked bradycardia, recurrent late and variable decelerations, and absent variability.

  • Normal pattern. In contrast, a normal baseline rate with normal, moderate variability and accelerations, and absence of periodic patterns (decelerations) predicts fetal well-being.

  • Tips on interpretation. Deciphering fetal heart rate patterns entails making observations over time. Many patterns acquire increased significance when there is a trend toward persistent, significant departures from baseline with decreased variability, loss of accelerations, or persistent episodic or periodic decelerations, particularly with loss of variability.

True or false: Electronic fetal monitoring reduces the incidence of cerebral palsy and infant morbidity and mortality.

Unfortunately, the statement is false, although patients continue to believe it is true. As a result, a large proportion of obstetrics liability cases center on electronic fetal monitoring (EFM): 43% of all lawsuits alleging obstetric malpractice, 52% of cases involving a stillborn fetus or neonatal death, and 66% of cases involving a neurologically impaired infant.1

Sign in now to read more...

Back to top


Advertisement



ADVERTISEMENT   

ADVERTISEMENT   
ADVERTISEMENT   
Subscribe to our e-mail alert. We'll notify you of upcoming articles every month—and send you links to them before they are published.

Changing your e-mail address?
 
INSTANT POLL
What nonhormonal menopause interventions have you found to be effective?

ADVERTISEMENT